Correlation and Clinical Impact of Ambulatory, Home, and Office Measurements in Hypertensive Patients

Öz

Aim: Hypertension is a major cardiovascular risk factor and the most common chronic disease. Being far from the targeted level in diagnosis and treatment has led to frequent questioning of measurement methods. Although out-of-office measurements are gaining prominence, the reliability and clinical effects of office and out-of-office measurement methods are open to question in terms of both usability and correlation. Our aim in this study was to evaluate the correlation of ambulatory, home, and office measurements and their clinical implications in hypertensive patients. Material and Method: We evaluated out-of-office blood pressure measurements of patients who were followed up with a diagnosis of hypertension. Patients who were scheduled to have ambulatory blood pressure measurements were asked to have home measurements five days before this measurement. Oscillometric and auscultatory methods used for office measurements. Home measurements were performed with the patient’s own calibrated devices. Ambulatory measurements were performed after five days of home follow-up. Results: The study included 463 patients with a mean age of 49±15 years, 52% of whom were women. The number of patients diagnosed with non-regulated hypertension, based on home (256) and office (220) measurements, was much higher than the number of patients based on daytime (63) and average (87) ambulatory measurements. Among the patients considered regulated according to daytime ambulatory measurements, 157 (71.4%) were evaluated as hypertension according to office blood pressure, and 193 (75.4%) were assessed as non-regulated hypertension according to home blood pressure. When the correlation between blood pressure measurements was analyzed, it was observed that there was a high correlation between home and office blood pressure (r: 0.922, p<0.001) and a low correlation between ambulatory measurements and home and office blood pressure (r: 0.438, r: 0.459, p<0.001). Conclusion: In a significant proportion of patients who were decided to be unregulated while being followed up with a diagnosis of hypertension due to office measurements, it was decided that the follow-up was regulated as a result of ambulatory measurements. The high correlation between home and office measurements and the low correlation between ambulatory measurements, which differs from these methods, are noteworthy.

Anahtar Kelimeler

• hypertension
• out-of-office blood pressure
• ambulatory blood pressure

Kaynakça

1. 1. Zhou B, Bentham J, Bixby H, Di Cesare M, Danaei G, Cowan JM et al. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population­based measurement studies with 19.1 million participants. Lancet 2017; 389: 37–55.
2. 2. Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmerfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/ APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2018; 138: e426–e83.
3. 3. Ettehad D, Emdin CA, Kiran A, Anderson GS, Callender T, Emberson J, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and metaanalysis. Lancet 2016; 387: 957–67.
4. 4. Verdecchia P, Gentile G, Angeli F, Mazzotta G, Mancia G, Reboldi G. Influence of blood pressure reduction on composite cardiovascular endpoints in clinical trials. Journal of Hypertension 2010; 28: 1356–65.
5. 5. Yusuf S, Wood D, Ralston J, & Reddy K. S, (2015). The World Heart Federation's vision for worldwide cardiovascular disease prevention. Lancet, 386(9991), 399-402.
6. 6. Hansen TW, Kikuya M Thijs L, Björklund-Bodegård K, Kuznetsova T, Ohkubo T et al.; IDACO investigators. (2007). Prognostic superiority of daytime ambulatory over conventional blood pressure in four populations: a meta-analysis of 7030 individuals. Journal of hypertension, 25(8), 1554-64.
7. 7. Niiranen TJ, Asayama K, Thijs L, Johansson JK, Ohkubo T, Kikuya M, et al. Outcome-driven thresholds for home blood pressure measurement: International Database of HOme blood pressure in relation to Cardiovascular Outcome. Hypertension 2013; 61:27–34.
8. 8. Shimada K, Kario K, Kushiro T, Teramukai S, Zenimura N, Ishikawa Y, et al. (2016). Prognostic significance of on-treatment home and clinic blood pressure for predicting cardiovascular events in hypertensive patients in the HONEST study. Journal of Hypertension, 34(8), 1520-7.

9. 9. Liu LS, Wu ZS, Wang JG, Wang W et al. 2018 Chinese guidelines for prevention and treatment of hypertension­A report of the revision committee of Chinese Guidelines for. Prevention and Treatment of Hypertension. J Geriatr Cardiol 2019; 16: 182–241.
10. 10. Nicholas R Jones, Terry McCormack, Margaret Constanti, Richard J 2019 Diagnosis and management of hypertension in adults: NICE guideline update McManus British Journal of General Practice 2020; 70 (691): 90-91.
11. 11. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. J Hypertens 2018; 36: 1953–2041.
12. 12. Aydogdu S, Guler K, Bayram F, Altun B, Derici U, Abacı A, et al. (2019). Turk hipertansiyon uzlası raporu 2019. Turk Kardiyol Dern Ars, 47(6), 535-46.
13. 13. Banegas JR, Ruilope LM, de la Sierra A, Vinyoles E, Gorostidi M, de la Cruz JJ, et al. Relationship between clinic and ambulatory blood­pressure measurements and mortality. N Engl J Med 2018; 378: 1509–20.
14. 14. Mancia G, Zanchetti A, Agabiti-Rosei E, Benemio G, De Cesaris R, Fogari R, et al. Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy: SAMPLE Study Group–Study on Ambulatory Monitoring of Blood Pressure and Lisinopril Evaluation. Circulation. 1997; 95:1464–70.
15. 15. Salles GF, Leite NC, Pereira BB, Nascimento EM, Cardoso CR. (2013). Prognostic impact of clinic and ambulatory blood pressure components in high-risk type 2 diabetic patients: the Rio de Janeiro Type 2 Diabetes Cohort Study. Journal of hypertension, 31(11), 2176-86.
16. 16. Thijs L, Hansen TW, Kikuya M, Björklund-Bodegård, K, Li Y, Dolan E, ... & IDACO Investigators. (2007). The International Database of Ambulatory Blood Pressure in relation to Cardiovascular Outcome (IDACO): protocol and research perspectives. Blood pressure monitoring, 12(4), 255-62.
17. 17. Chen Y, Liu J, Zhen Z, Zuo Y, Lin Q, Liu M, et al. Assessment of left ventricular function and peripheral vascular arterial stiffness in patients with dipper and nondipper hypertension. J Investig Med 2018; 66: 319–24.
18. 18. Wang C, Deng W, Gong WY, Zhang J, Zhang QZ, Ye ZC, et al. Nocturnal hypertension correlates better with target organ damage in patients with chronic kidney disease than a nondipping pattern. J Clin Hypertens 2015; 17: 792–801.
19. 19. Kawauchi D, Hoshide S and Kario K. Morning home blood pressure and cardiovascular events in a Japanese general practice population over 80 years old: the J­HOP study. Am J Hypertens 2018; 31: 1190–6.
20. 20. Divison­Garrote JA, Banegas JR, De la Cruz JJ, Escobar-Cervantes C, De la Sierra A, Gorostidi M, et al. Hypotension based on office and ambulatory monitoring blood pressure. Prevalence and clinical profile among a cohort of 70,997 treated hypertensives. J Am Soc Hypertens 2016; 10: 714–23.
21. 21. Lovibond K, Jowett S, Barton P, Caulfield M, Heneghan C, Hobbs FD, et al. Cost-effectiveness of options for the diagnosis of high blood pressure in primary care: a modelling study. Lancet. 2011; 378:1219–30. doi: 10.1016/S0140-6736(11)61184-7
22. 22. Siu AL; U.S. Preventive Services Task Force. Screening for high blood pressure in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2015; 163:778–786. doi: 10.7326/M15-2223
23. 23. Duan Y, Xie Z, Dong F, Wu Z, Lin Z, Sun N, et al. Effectiveness of home blood pressure telemonitoring: a systematic review and meta­analysis of randomised controlled studies. J Hum Hypertens 2017; 31: 427–37.
24. 24. Niiranen TJ, Hänninen M, Johansson J, Reunanen A, Jula AM. Home­Measured Blood Pressure Is a Stronger Predictor of Cardiovascular Risk Than Office Blood Pressure. Hypertension 2010; 55: 13461351.
25. 25. Uallachain GN, Murphy G, Avalos G. The RAMBLER study: the role of ambulatory blood pressure measurement in routine clinical practice a cross-sectional study. Ir Med J 2006; 99:276–79.
26. 26. Stergiou GS, Skeva II, Zourbaki AS, Mountokalakis TD. Selfmonitoring of blood pressure at home: how many measurements are needed? J Hypertens. 1998; 16:725–31.
27. 27. Shimbo D, Abdalla M, Falzon L, Townsend RR, Muntner P. Studies comparing ambulatory blood pressure and home blood pressure on cardiovascular disease and mortality outcomes: a systematic review. J Am Soc Hypertens. 2016; 10:224–34.e17.
28. 28. Sega R, Facchetti R, Bombelli M, Cesana G, Corrao G, Grassi G, et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation. 2005; 111:1777-83.
29. 29. Shimbo D, Pickering TG, Spruill TM, Abraham D, Schwartz JE, Gerin W. Relative utility of home, ambulatory, and office blood pressures in the prediction of end-organ damage. Am J Hypertens. 2007; 20:476–82.
30. 30. Johnson KA, Partsch DJ, Rippole LL, McVey DM. Reliability of self-reported blood pressure measurements. Arch Intern Med. 1999; 159:2689–93.
31. 31. Logan AG, Dunai A, McIsaac WJ, Irvine MJ, Tisler A. Attitudes of primary care physicians and their patients about home blood pressure monitoring in Ontario. J Hypertens. 2008; 26:446–52.
32. 32. Parati G, Omboni S, Albini F, Piantoni L, Giuliano A, Revera M, et al. TeleBPCare Study Group. Home blood pressure telemonitoring improves hypertension control in general practice. The TeleBPCare study. J Hypertens 2009; 27:198–203.
33. 33. Wilson MD, Johnson KA. Hypertension management in managed care: the role of home blood pressure monitoring. Blood Press Monit 1997; 2:201–06.
34. 34. Parati G, Pickering TG. Home blood-pressure monitoring: U.S. and European consensus. Lancet 2009; 373:876-8.
35. 35. Fletcher B. R, Hartmann-Boyce J, Hinton L, McManus R. J. (2015). The effect of self-monitoring of blood pressure on medication adherence and lifestyle factors: a systematic review and meta-analysis. American journal of hypertension, 28(10), 1209-21.
36. 36. Mengden T, Weisser B. (2021). Monitoring of Treatment for Arterial Hypertension: The Role of Office, Home, and 24 h Ambulatory Blood Pressure Measurement. Dtsch Arztebl Int. 2021 Jul 12;118(27-28):473-478.
37. 37. Ragot S, Genès N, Vaur L, Herpin D. (2000). Comparison of three blood pressure measurement methods for the evaluation of two antihypertensive drugs: feasibility, agreement, and reproducibility of blood pressure response. American journal of hypertension, 13(6), 632-9.
38. 38. Viera AJ, Lingley K, Hinderliter AL. (2011). Tolerability of the Oscar 2 ambulatory blood pressure monitor among research participants: a cross-sectional repeated measures study. BMC medical research methodology, 11(1), 1-7.
39. 39. Krakoff LR. Cost-effectiveness of ambulatory blood pressure: a reanalysis. Hypertension. 2006; 47:29–34.
40. 40. Ardahanli I, Akhan O, Aslan R, Akyuz O. The relationship between blood pressure regulation and alexithymia variability in newly diagnosed essential hypertension patients. Journal of Surgery and Medicine 5.8 (2021): 768-771.